EDIT Q3 2025 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$256M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+12265.6% YoY

Gross Profit

$8M100.0% margin

Operating Income

-$25M-325.4% margin

Net Income

-$25M-333.0% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

+110.8%

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$31M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$202M

Total Liabilities

$188M

Stockholders' Equity

$13M

Cash & Equivalents

$166M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$61,000	+12265.6%
Gross Profit	$8M	-$2M	+590.4%
Operating Income	-$25M	-$66M	+62.6%
Net Income	-$25M	-$62M	+59.6%

Revenue Segments

Reportable Segment

$8M100%